ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,488Medicare Part D Prescriptions Filled, Including Refills

Rank: 737 out of 2888

$710K Total Retail Price of All Prescriptions

Rank: 458 out of 2888

160 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

23% of this provider’s 160 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 7,397 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$84 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

53 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
NAMENDA 331 315 1 34
LEVOTHYROXINE SODIUM 260 226 2 1
SIMVASTATIN 257 214 3 2
FUROSEMIDE 255 237 4 6
POTASSIUM CHLORIDE 236 205 5 14
HYDROCODONE-ACETAMINOPHEN 225 208 S3 6 4
LISINOPRIL 225 198 6 3
AMLODIPINE BESYLATE 210 195 8 5
DONEPEZIL HCL 208 187 9 26
GABAPENTIN 196 145 10 13
CYMBALTA 186 165 11 44
SERTRALINE HCL 157 145 12 27
WARFARIN SODIUM 129 89 13 22
METOPROLOL TARTRATE 128 121 14 10
TRAZODONE HCL 117 107 15 43
TRAMADOL HCL 112 93 16 16
CARVEDILOL 95 83 17 21
ESCITALOPRAM OXALATE 89 89 18 62
MIRTAZAPINE 89 89 18 54
BENZTROPINE MESYLATE 86 52 R 20 191
QUETIAPINE FUMARATE 86 78 20 66
HUMALOG 86 72 20 166
CLONIDINE HCL 85 80 23 39
METOPROLOL SUCCINATE 84 78 24 11
OLANZAPINE 83 80 25 137
CITALOPRAM HBR 82 70 26 24
LEVETIRACETAM 80 51 27 103
EXELON 77 77 28 106
DIOVAN 76 70 29 35
LIDODERM 72 68 30 105
RISPERIDONE 69 63 31 72
TAMSULOSIN HCL 69 69 31 29
ATORVASTATIN CALCIUM 69 68 31 9
LANTUS 68 62 34 45
CLOZAPINE 64 15 35 367
CLOPIDOGREL 64 62 35 30
ALENDRONATE SODIUM 60 60 37 23
DIVALPROEX SODIUM 57 48 38 100
METFORMIN HCL 57 41 38 8
NOVOLOG 54 50 40 114
PLAVIX 53 48 41 40
OMEPRAZOLE 51 51 42 7
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.